Biotech Values

[libertyhound]

My understanding is Vidaza is a precursor of Dacogen...so eventual efficacy should be similar. MOGN reported a 30% increase in Dacogen sales, though there may be short term hit to sales due to the recent Vidaza results.

SUPG seems a screaming buy here, and a prime take out target for MOGN. I began buying back in at the close today, though I really hope this absurd drop continues for a bit longer.